Abstract Recently, Salidroside (Sal) has been demonstrated to suppress hepatic stellate cell (HSC) activation, a crucial event for liver fibrosis. Moreover, Sal reported decrease hepatocyte injury. A growing number of reports have indicated that the crosstalk between hepatocytes and HSCs is very fibrosis development. Whether Sal-treated could inhibit HSC activation unclear. Exosomes, as vital v...